Related Experiment Video
Updated: Jun 8, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Future costs in cost-effectiveness analysis: an empirical assessment
Marie Kruse1, Jan Sørensen, Dorte Gyrd-Hansen
1Centre for Applied Health Services Research and Technology Assessment, University of Southern Denmark, Odense, Denmark. mkru@cast.sdu.dk
Summary
Including future societal contributions in cost-effectiveness analysis significantly alters intervention rankings, especially for younger populations. This impacts health care and promotion intervention assessments by accounting for net consumption and production values.
Area of Science:
- Health Economics
- Public Health Policy
Background:
- Cost-effectiveness analysis (CEA) is crucial for resource allocation in healthcare.
- Societal perspective in CEA traditionally focuses on direct healthcare costs, often omitting broader economic impacts.
Purpose of the Study:
- To assess the impact of including societal production and consumption measures on the cost-effectiveness ratio of health interventions.
- To provide age-specific cost figures for CEA from a societal viewpoint.
Main Methods:
- Defined net incremental consumption as change in consumption minus change in production.
- Utilized 2005 Danish population register data to estimate annual production and consumption values for 1-year age groups.
- Calculated net consumption over remaining lifetime and per life year gained.
Main Results:
- Net consumption varies significantly with age, impacting CEA ratios.
- Including net incremental consumption altered cost-effectiveness ratios by up to €21,000 across age groups.
- Younger age groups, particularly 30-year-olds, showed significant cost reductions due to future societal contributions.
Conclusions:
- The study provides valuable cost data for CEA adopting a societal perspective, incorporating future economic impacts.
- Age-specific net consumption significantly influences the relative cost-effectiveness of health interventions.
- Excluding future societal costs can bias CEA, potentially favoring interventions for older populations; findings are generalizable to countries with similar social/economic structures.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
01:18Introduction To Survival Analysis
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
The primary goal of survival analysis is to estimate survival time—the time until a...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...